17 September 2008 10:53 [Source: ICIS news]
LONDON (ICIS news)--LANXESS is on track to achieving its financial goals for 2008 and plans to grow the business through investments in facilities and research and development (R&D) as well as strategic acquisitions, the company’s chairman said on Wednesday.
“I’m very confident for the foreseeable future despite the increasingly difficult market environment," said LANXESS board of management chairman Axel Heitmann at the group’s third international media day in ?xml:namespace>
He added that following a good third quarter, the German specialty chemicals company continued to expect further operational sales growth and earnings before interest, tax, depreciation and amortisation (EBITDA) pre-exceptionals of more than €700m ($987m).
Heitmann said the company’s strategy going forward would be to supplement organic growth by investing in existing business units, making selective acquisitions to progressively broaden and strengthen the group’s portfolio and to research and develop innovative products.
Along with projects in
The group planned to launch its own company in
The Russian chemicals market is growing at a rate in excess of 5% a year, with growth in the automotive industry at 9%/year, 5% in the electronics sector and 8% in the construction industry, LANXESS added.
“We plan to derive significant benefit from this expansion,” said Heitmann. “We have identified substantial development potential for LANXESS and will systematically enlarge our market shares. We consider annual sales growth of up to 20% a realistic prospect.”
The company will also invest €35m to increase caprolactam capacity in
LANXESS said it would then have invested a total of €1bn worldwide by 2009, with over half of this amount spent at the main German sites.
“These capital expenditures are helping to ensure our global competitiveness,” said Heitmann.
LANXESS has already earmarked some €250m for further investment projects in
LANXESS CFO Matthias Zachert said at the media day that the company was not directly affected by the current crisis in the financial markets.
“We have renegotiated our credit facilities over the past few years on favourable terms, most recently in fall 2007, thereby safeguarding the group’s long-term liquidity through 2014,” he said.
($1 = €0.71)
To discuss issues facing the chemical industry go to ICIS connect
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|